Exact Mass: 523.2839864
Exact Mass Matches: 523.2839864
Found 114 metabolites which its exact mass value is equals to given mass value 523.2839864
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
LPS(18:1)
1-Oleoylglycerophosphoserine is a phosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PS(18:1(9Z)/0:0), in particular, consists of two 9Z-octadecenoyl chains at positions C-1 and C-2. Phosphatidylserine or 1,2-diacyl-sn-glycero-3-phospho-L-serine is distributed widely among animals, plants and microorganisms. Phosphatidylserine is an acidic (anionic) phospholipid with three ionizable groups, i.e. the phosphate moiety, the amino group and the carboxyl function. As with other acidic lipids, it exists in nature in salt form, but it has a high propensity to chelate to calcium via the charged oxygen atoms of both the carboxyl and phosphate moieties, modifying the conformation of the polar head group. This interaction may be of considerable relevance to the biological function of phosphatidylserine. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Phosphatidylserines typically carry a net charge of -1 at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PS biosynthesis involves an exchange reaction of serine for ethanolamine in PE.
LysoPS(18:1(9Z)/0:0)
LysoPS(18:1(9Z)/0:0) is a lysophosphatidylserine. It is a glycerophospholipid in which a phosphorylserine moiety occupies a glycerol substitution site. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic. However, it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Lysophosphatidylserines can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. LysoPS(18:1(9Z)/0:0), in particular, consists of one chain of oleic acid at the C-1 position.
Tyr Val Ser Arg
Tobramycin, N-propionyl derivative likely
C21H41N5O10 (523.2853286000001)
2-amino-3-[hydroxy-[2-hydroxy-3-[octadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
Phe Lys Met Val
Phe Lys Val Met
Phe Met Lys Val
Phe Met Val Lys
Phe Arg Thr Thr
Phe Thr Arg Thr
Phe Thr Thr Arg
Phe Val Lys Met
Phe Val Met Lys
Lys Phe Met Val
Lys Phe Val Met
Lys Met Phe Val
Lys Met Val Phe
Lys Val Phe Met
Lys Val Met Phe
Met Phe Lys Val
Met Phe Val Lys
Met Lys Phe Val
Met Lys Val Phe
Met Val Phe Lys
Met Val Lys Phe
Arg Phe Thr Thr
Arg Ser Val Tyr
Arg Ser Tyr Val
Arg Thr Phe Thr
Arg Thr Thr Phe
Arg Val Ser Tyr
Arg Val Tyr Ser
Arg Tyr Ser Val
Arg Tyr Val Ser
Ser Arg Val Tyr
Ser Arg Tyr Val
Ser Val Arg Tyr
Ser Val Tyr Arg
Ser Tyr Arg Val
Ser Tyr Val Arg
Thr Phe Arg Thr
Thr Phe Thr Arg
Thr Arg Phe Thr
Thr Arg Thr Phe
Thr Thr Phe Arg
Thr Thr Arg Phe
Val Phe Lys Met
Val Phe Met Lys
Val Lys Phe Met
Val Lys Met Phe
Val Met Phe Lys
Val Met Lys Phe
Val Arg Ser Tyr
Val Arg Tyr Ser
Val Ser Arg Tyr
Val Ser Tyr Arg
Val Tyr Arg Ser
Val Tyr Ser Arg
Tyr Arg Ser Val
Tyr Arg Val Ser
Tyr Ser Arg Val
Tyr Ser Val Arg
Tyr Val Arg Ser
PS(18:1/0:0)
PS(18:1/0:0)[U]
NA 27:7;O8
LPS 18:1
1-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2S,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2R,3R)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
1-[[(2S,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-3-(4-methoxyphenyl)-1-methylurea
2-amino-3-[hydroxy-[2-hydroxy-3-[(Z)-octadec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
FR901465
A spiro-epoxide with potent cytotoxic activity against human tumour cells. It is isolated from Pseudomonas sp. no.2663.
(3s,3ar,4s,6s,6ar,10s,12r,15r,15ar)-1,6,12-trihydroxy-3-[(4-methoxyphenyl)methyl]-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindol-15-yl acetate
3-[(1r,3s,4s,8s,11s,12s,13r,14r,15s,16s,17s,18r,20s,23r)-12,14,15,16,18-pentahydroxy-8,12,23-trimethyl-21-oxo-22-oxa-6-azahexacyclo[18.2.1.0¹,¹⁷.0³,¹⁶.0⁴,¹³.0⁶,¹¹]tricosan-23-yl]propanoic acid
(2z,4s)-4-(acetyloxy)-n-[(2r,3r,5s,6s)-2,5-dimethyl-6-[(2e,4e)-3-methyl-5-[(3s,4r,5r,7r,8r)-4,7,8-trihydroxy-7-methyl-1,6-dioxaspiro[2.5]octan-5-yl]penta-2,4-dien-1-yl]oxan-3-yl]pent-2-enimidic acid
aconosine; 14-benzoyl,8-ac
{"Ingredient_id": "HBIN014589","Ingredient_name": "aconosine; 14-benzoyl,8-ac","Alias": "NA","Ingredient_formula": "C31H41NO6","Ingredient_Smile": "NA","Ingredient_weight": "523.66","OB_score": "NA","CAS_id": "126234-21-7","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "7184","PubChem_id": "NA","DrugBank_id": "NA"}